Valeant Pharmaceuticals reported CAD328M in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Amgen AMGN:US $ 2333M 204M
Ani Pharmaceuticals ANIP:US $ -6638000 9.72M
Aphria Inc APH:CN C$ -95267000 48.54M
Aurora Cannabis Inc ACB:CN C$ -126834000 32.63M
Biogen BIIB:US $ 1030.1M 12.3M
Bristol Myers Squibb BMY:US $ 2967M 411M
Canopy Growth Corp WEED:CN -92682000 59.14M
Catalent CTLT:US $ 253.3M 60.4M
Corcept Therapeutics CORT:US $ 31.94M 12.3M
Danaher DHR:US $ 2005M 8M
Drreddys Laboratories RDY:US 6.5B 909M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Endo International Ordinary Shares ENDP:US $ 195.54M 19.6M
Gilead Sciences GILD:US $ 2262M 639M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Horizon Pharma HZNP:US 213.77M 303.22M
JAZZ PHA JAZZ:US -69590000 231.71M
Lannett LCI:US $ -4934000 7.78M
Nektar Therapeutics NKTR:US $ -110205000 813K
Pacira Pharmaceuticals PCRX:US $ 34.99M 13.68M
Perrigo Ordinary Shares PRGO:US $ 44.1M 18.3M
Phibro Animal Health PAHC:US $ 19.16M 974K
Prestige Brands PBH:US $ 91.34M 20.4M
Revance Therapeutics RVNC:US $ -70337000 325K
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Valeant Pharmaceuticals VRX:CN C$ 328M 50M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
Zoetis ZTS:US $ 726M 33M